Skip to main content
. 1999 Apr 17;318(7190):1031–1035. doi: 10.1136/bmj.318.7190.1031

Table 1.

Details of treatment allocation and blinding. All tablets or capsules given daily

Treatment group and weeks Tablets/capsules received
T12
1-12 1 terbinafine (250 mg)
13-16 1 placebo tablet
1, 5, 9, 13 4 placebo capsules
T16
1-16 1 terbinafine (250 mg)
1, 5, 9, 13 4 placebo capsules
I3
1-16 1 placebo tablet
1, 5, 9 4 itraconazole (100 mg)
13 4 placebo capsules
I4
1-16 1 placebo tablet
1, 5, 9, 13 4 itraconazole (100 mg)